Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells.
about
Murine xenogeneic models of myelodysplastic syndrome: an essential role for stroma cellsSerine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell-cell adhesion.TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection.Contribution of bone microenvironment to leukemogenesis and leukemia progression.Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis.Angiogenesis and acute myeloid leukemia.The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?The multi-functional cellular adhesion molecule CD44 is regulated by the 8;21 chromosomal translocation.The inflammatory microenvironment in MDS.Enhanced differentiation of embryonic stem cells using co-cultivation with hepatocytes.Hepatocyte growth factor receptor c-MET is associated with FAS and when activated enhances drug-induced apoptosis in pediatric B acute lymphoblastic leukemia with TEL-AML1 translocation.Coculture of native human acute myelogenous leukemia blasts with fibroblasts and osteoblasts results in an increase of vascular endothelial growth factor levels.Soluble hepatocyte growth factor (sHGF) and vascular endothelial growth factor (sVEGF) in adult acute myeloid leukemia: relationship to disease characteristics.Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma.Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia.High serum hepatocyte growth factor level in patients with non-Hodgkin's lymphoma.Phase I study of the anti-MET antibody onartuzumab in patients with solid tumors and MET-positive lung cancer.
P2860
Q27023457-294D2D27-F90B-4B22-AE95-E884050822E9Q33588161-D8CB8787-683D-4FC0-A015-170F5CC124A6Q33769592-FF74D501-66D2-4241-A2F7-FFFCC4E76C0FQ35037058-186BC475-AF60-4B4A-B408-DD71979BADA2Q37973279-5E46360C-29B0-4BEE-B411-190C037CE2D9Q38160129-0F98E544-A91A-4CE5-B41B-FD85469D496AQ38239580-DEF25573-3FF8-4AE8-B968-AB6D861C6B2FQ38299682-F8BF11FF-D646-4278-BD35-7E5E5E767B02Q38348119-6CAA41AE-3A63-47FD-AF16-0029FFF257ECQ39969433-6EB254E5-5B3E-4203-851E-79674D88D93BQ40098619-86E2325F-B9F4-49CE-A52F-8AE1C2B128BDQ40478229-8EAFA05A-09F7-4712-A759-23B4CA6DC54EQ43838003-E1534C37-C135-438E-B12D-00A41E32B641Q43890944-54B5A755-8192-482E-BFB5-DF84221ED05FQ44421351-7A0F8A15-4585-4F4F-98BB-759CF7E8DF32Q46600643-8788C947-4013-41AC-9845-E726D7232157Q53302536-C13795B7-FA72-4EB9-867C-E259B5D96DCBQ53581780-708F8AAF-CE46-4392-9579-530BFA4420D3
P2860
Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Hepatocyte growth factor/scatt ...... ion of myeloid leukemic cells.
@en
Hepatocyte growth factor/scatter factor
@nl
type
label
Hepatocyte growth factor/scatt ...... ion of myeloid leukemic cells.
@en
Hepatocyte growth factor/scatter factor
@nl
prefLabel
Hepatocyte growth factor/scatt ...... ion of myeloid leukemic cells.
@en
Hepatocyte growth factor/scatter factor
@nl
P2093
P356
P1433
P1476
Hepatocyte growth factor/scatt ...... ion of myeloid leukemic cells.
@en
P2093
Bourhis JH
Gerritsen WR
Nakamura T
Voermans C
de Gast GC
van den Berk PC
P2888
P304
P356
10.1038/SJ.LEU.2401080
P577
1998-08-01T00:00:00Z